Schizophrenia: Overview and Treatment Options - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Antipsychotics are the drugs prescribed to treat psychotic disorders; however, patients often
fail to adhere to their treatment, and this has a severe negative effect on prognosis in these …

Despite their widespread use, long-acting injectable (LAI) antipsychotics (APs) are often
regarded with some negativity because of the assumption of punishment, control and …

Schizophrenia is a chronic, heterogeneous neurodevelopmental disorder that has complex
symptoms and uncertain etiology. Mounting evidence indicates the involvement of genetics …

Objective: Antipsychotic medication non-adherence has detrimental effects on patients'
clinical outcome. It is unclear which risk factors affect adherence most and which …

ObjectiveNonadherence to antipsychotic medication is highly prevalent in patients with
schizophrenia and has a deleterious impact on the course of the illness. This review seeks …

Schizophrenia is a debilitating chronic disease that requires lifelong medical care and
supervision. Even with treatment, the majority of patients relapse within 5 years, and suicide …

Schizophrenia elevates the risk for aggressive behavior and violent crime, and different
approaches have been used to manage this problem. The results of such treatments vary …

Abstract The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) obtained a
sample of 1493 chronic schizophrenia patients. The European First Episode Schizophrenia …

Objective: This study evaluated the efficacy, safety, and tolerability of aripiprazole lauroxil, a
novel long-acting injectable atypical antipsychotic, for the treatment of schizophrenia …